Prothera Biologics, LLC
Publicly observedProvidence, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Providence | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Prothera Biologics, LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | ZAE3CABBMZE9 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant22 Sept 2023Publicly observed
NIH SBIR/STTR award: Inter-alpha Inhibitors in Experimental Necrotizing Enterocolitis
USD 50,184.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
- Grant15 Aug 2018Publicly observed
NIH SBIR/STTR award: Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis
USD 954,189.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant15 Aug 2018Publicly observed
NIH SBIR/STTR award: Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis
USD 971,267.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.